从癌症基因组图谱中描述 DNA 甲基化改变。
Characterizing DNA methylation alterations from The Cancer Genome Atlas.
出版信息
J Clin Invest. 2014 Jan;124(1):17-23. doi: 10.1172/JCI69740. Epub 2014 Jan 2.
Abstract
The Cancer Genome Atlas (TCGA) Research Network is an ambitious multi-institutional consortium effort aimed at characterizing sequence, copy number, gene (mRNA) expression, microRNA expression, and DNA methylation alterations in 30 cancer types. TCGA data have become an extraordinary resource for basic, translational, and clinical researchers and have the potential to shape cancer diagnostic and treatment strategies. DNA methylation changes are integral to all aspects of cancer genomics and have been shown to have important associations with gene expression, sequence, and copy number changes. This Review highlights the knowledge gained from DNA methylation alterations in human cancers from TCGA.
摘要
癌症基因组图谱（TCGA）研究网络是一项雄心勃勃的多机构联盟努力，旨在描述 30 种癌症类型中的序列、拷贝数、基因（mRNA）表达、microRNA 表达和 DNA 甲基化改变。TCGA 数据已成为基础、转化和临床研究人员的宝贵资源，并有潜力改变癌症诊断和治疗策略。DNA 甲基化改变是癌症基因组学各个方面的重要组成部分，并且已经显示出与基因表达、序列和拷贝数改变的重要关联。这篇综述强调了从 TCGA 人类癌症中的 DNA 甲基化改变中获得的知识。
相似文献
1
Characterizing DNA methylation alterations from The Cancer Genome Atlas.从癌症基因组图谱中描述 DNA 甲基化改变。
J Clin Invest. 2014 Jan;124(1):17-23. doi: 10.1172/JCI69740. Epub 2014 Jan 2.
2
Review of the alterations in DNA methylation in esophageal squamous cell carcinoma.食管鳞状细胞癌中 DNA 甲基化改变的综述。
Surg Today. 2013 Dec;43(12):1355-64. doi: 10.1007/s00595-012-0451-y. Epub 2013 Jan 5.
3
Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations.具有上皮样特征的间变性星形细胞瘤，一种新的 IDH 野生型神经胶质瘤分子类型，具有反复出现的 MAPK 通路、CDKN2A/B 和 ATRX 改变。
Acta Neuropathol. 2018 Aug;136(2):273-291. doi: 10.1007/s00401-018-1837-8. Epub 2018 Mar 21.
4
Methylation of BRCA1 and MGMT genes in white blood cells are transmitted from mothers to daughters.BRCA1 和 MGMT 基因在白细胞中的甲基化从母亲遗传给女儿。
Clin Epigenetics. 2018 Jul 26;10(1):99. doi: 10.1186/s13148-018-0529-5.
5
Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy.在经标准放化疗治疗的异柠檬酸脱氢酶1（IDH1）野生型原发性胶质母细胞瘤中，人端粒酶逆转录酶（TERT）启动子突变可使甲基鸟嘌呤-DNA甲基转移酶（MGMT）启动子甲基化带来生存优势。
Neuro Oncol. 2017 Mar 1;19(3):394-404. doi: 10.1093/neuonc/now189.
6
Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH-wildtype glioblastoma.CDKN2A 纯合缺失联合甲基化 MGMT 状态对 IDH 野生型胶质母细胞瘤的临床意义。
Cancer Med. 2021 May;10(10):3177-3187. doi: 10.1002/cam4.3860. Epub 2021 Apr 10.
7
Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network.新诊断胶质母细胞瘤患者无进展生存期和总生存期的分子预测指标：德国胶质瘤网络的一项前瞻性转化研究
J Clin Oncol. 2009 Dec 1;27(34):5743-50. doi: 10.1200/JCO.2009.23.0805. Epub 2009 Oct 5.
8
Loss of ATRX, associated with DNA methylation pattern of chromosome end, impacted biological behaviors of astrocytic tumors.ATRX的缺失与染色体末端的DNA甲基化模式相关，影响了星形细胞瘤的生物学行为。
Oncotarget. 2015 Jul 20;6(20):18105-15. doi: 10.18632/oncotarget.3906.
9
Aberrant gene promoter methylation of E-cadherin, p16 , p14 , and MGMT in Epstein-Barr virus-associated oral squamous cell carcinomas.爱泼斯坦-巴尔病毒相关口腔鳞状细胞癌中E-钙黏蛋白、p16、p14和O6-甲基鸟嘌呤-DNA甲基转移酶的异常基因启动子甲基化
Med Oncol. 2017 Jul;34(7):128. doi: 10.1007/s12032-017-0983-5. Epub 2017 Jun 2.
10
Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas.结直肠腺瘤中 hMLH1、MGMT 和 CDKN2A/p16 的启动子甲基化状态。
World J Gastroenterol. 2010 Jul 28;16(28):3553-60. doi: 10.3748/wjg.v16.i28.3553.
引用本文的文献
1
Evaluation of the HumanMethylationEPIC v2.0 Bead Chip Using Low Quality and Quantity DNA Samples.使用低质量和低数量DNA样本对HumanMethylationEPIC v2.0芯片进行评估
Biol Proced Online. 2025 Aug 21;27(1):34. doi: 10.1186/s12575-025-00292-3.
2
Salivary cell-free DNA methylation analysis for oncological monitoring of surgical resection of oral squamous cell carcinoma.用于口腔鳞状细胞癌手术切除肿瘤学监测的唾液游离DNA甲基化分析
Front Oral Health. 2025 Jun 11;6:1614371. doi: 10.3389/froh.2025.1614371. eCollection 2025.
3
DNA methylation in melanoma immunotherapy: mechanisms and therapeutic opportunities.黑色素瘤免疫治疗中的DNA甲基化：机制与治疗机遇
Clin Epigenetics. 2025 Apr 30;17(1):71. doi: 10.1186/s13148-025-01865-5.
4
Decoding the complexity: mechanistic insights into comorbidities in idiopathic pulmonary fibrosis.解读复杂性：特发性肺纤维化合并症的机制洞察
Eur Respir J. 2025 May 22;65(5). doi: 10.1183/13993003.02418-2024. Print 2025 May.
5
High Expression of ZNF208 Predicts Better Prognosis and Suppresses the Tumorigenesis of Breast Cancer.ZNF208的高表达预示着更好的预后并抑制乳腺癌的肿瘤发生。
Clin Med Insights Oncol. 2024 Nov 29;18:11795549241301341. doi: 10.1177/11795549241301341. eCollection 2024.
6
Circulating tumor DNA methylation detection as biomarker and its application in tumor liquid biopsy: advances and challenges.循环肿瘤DNA甲基化检测作为生物标志物及其在肿瘤液体活检中的应用：进展与挑战
MedComm (2020). 2024 Nov 9;5(11):e766. doi: 10.1002/mco2.766. eCollection 2024 Nov.
7
Evaluation of a plasma cell-free DNA methylation test for colorectal cancer diagnosis: a multicenter clinical study.评估用于结直肠癌诊断的无细胞血浆 DNA 甲基化检测：一项多中心临床研究。
BMC Med. 2024 Oct 8;22(1):436. doi: 10.1186/s12916-024-03662-y.
8
ELF4 was a prognostic biomarker and related to immune infiltrates in glioma.ELF4是一种预后生物标志物，与胶质瘤中的免疫浸润相关。
J Cancer. 2024 Aug 6;15(15):5101-5117. doi: 10.7150/jca.96886. eCollection 2024.
9
Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer.生物信息学分析和验证与胃癌预测和预后相关的潜在标志物。
Int J Mol Sci. 2024 May 28;25(11):5880. doi: 10.3390/ijms25115880.
10
Comprehensive Bioinformatic Investigation of TP53 Dysregulation in Diverse Cancer Landscapes.全面的生物信息学研究揭示了不同癌症图谱中 TP53 的失调
Genes (Basel). 2024 Apr 30;15(5):577. doi: 10.3390/genes15050577.
本文引用的文献
1
The somatic genomic landscape of glioblastoma.胶质母细胞瘤的体细胞基因组景观。
Cell. 2013 Oct 10;155(2):462-77. doi: 10.1016/j.cell.2013.09.034.
2
Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2.IDH 突变型癌症的荟萃分析鉴定 EBF1 为 TET2 的相互作用伙伴。
Nat Commun. 2013;4:2166. doi: 10.1038/ncomms3166.
3
Comprehensive molecular characterization of clear cell renal cell carcinoma.透明细胞肾细胞癌的全面分子特征分析。
Nature. 2013 Jul 4;499(7456):43-9. doi: 10.1038/nature12222. Epub 2013 Jun 23.
4
Integrated genomic characterization of endometrial carcinoma.子宫内膜癌的综合基因组特征分析。
Nature. 2013 May 2;497(7447):67-73. doi: 10.1038/nature12113.
5
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.成人新发急性髓系白血病的基因组和表观基因组图谱。
N Engl J Med. 2013 May 30;368(22):2059-74. doi: 10.1056/NEJMoa1301689. Epub 2013 May 1.
6
Genome-wide profiling of 5-formylcytosine reveals its roles in epigenetic priming.全基因组 5- 羟甲基胞嘧啶图谱分析揭示了其在表观遗传引发中的作用。
Cell. 2013 Apr 25;153(3):678-91. doi: 10.1016/j.cell.2013.04.001. Epub 2013 Apr 18.
7
Genome-wide analysis reveals TET- and TDG-dependent 5-methylcytosine oxidation dynamics.全基因组分析揭示了 TET 和 TDG 依赖的 5-甲基胞嘧啶氧化动力学。
Cell. 2013 Apr 25;153(3):692-706. doi: 10.1016/j.cell.2013.04.002. Epub 2013 Apr 18.
8
Interplay between the cancer genome and epigenome.癌症基因组与表观基因组的相互作用。
Cell. 2013 Mar 28;153(1):38-55. doi: 10.1016/j.cell.2013.03.008.
9
IDH1 and IDH2 mutations in gliomas.胶质母细胞瘤中的 IDH1 和 IDH2 突变。
Curr Neurol Neurosci Rep. 2013 May;13(5):345. doi: 10.1007/s11910-013-0345-4.
10
Disruption of wild-type IDH1 suppresses D-2-hydroxyglutarate production in IDH1-mutated gliomas.野生型 IDH1 的破坏可抑制 IDH1 突变型胶质瘤中 D-2-羟戊二酸的产生。
Cancer Res. 2013 Jan 15;73(2):496-501. doi: 10.1158/0008-5472.CAN-12-2852. Epub 2012 Nov 30.
Zotero 插件